Search

everythinglearnresearchcommunity

for

Search:↓

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

Non-melanoma skin cancer in darker-skinned people can be misdiagnosed, so doctors need to be more aware to diagnose it correctly and early.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Docetaxel treatment for breast cancer can cause permanent hair loss.

High dose rate electronic brachytherapy is an effective and safe non-surgical treatment for nonmelanoma skin cancer with good cosmetic results after three years.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Finasteride's effects on prostate cancer are not clear from this text.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Male pattern baldness may be linked to prostate cancer risk.

Men and women may have different risks of getting skin cancer.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Understanding breast cancer requires considering both medical advancements and social influences.

The hedgehog signalling pathway is key in skin development and basal cell carcinoma, offering insights for prevention and treatment.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.